GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » ROIC %

Feedback (LSE:FDBK) ROIC % : -95.65% (As of Nov. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Feedback ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Feedback's annualized return on invested capital (ROIC %) for the quarter that ended in Nov. 2023 was -95.65%.

As of today (2024-06-21), Feedback's WACC % is 8.48%. Feedback's ROIC % is -90.59% (calculated using TTM income statement data). Feedback earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Feedback ROIC % Historical Data

The historical data trend for Feedback's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback ROIC % Chart

Feedback Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -138.58 -83.22 -63.85 -59.80 -73.05

Feedback Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.00 -59.94 -75.89 -80.41 -95.65

Competitive Comparison of Feedback's ROIC %

For the Health Information Services subindustry, Feedback's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feedback's ROIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Feedback's ROIC % distribution charts can be found below:

* The bar in red indicates where Feedback's ROIC % falls into.



Feedback ROIC % Calculation

Feedback's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in May. 2023 is calculated as:

ROIC % (A: May. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: May. 2022 ) + Invested Capital (A: May. 2023 ))/ count )
=-3.422 * ( 1 - 13.52% )/( (3.749 + 4.353)/ 2 )
=-2.9593456/4.051
=-73.05 %

where

Feedback's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Nov. 2023 is calculated as:

ROIC % (Q: Nov. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2023 ) + Invested Capital (Q: Nov. 2023 ))/ count )
=-4.27 * ( 1 - 7.28% )/( (4.353 + 3.925)/ 2 )
=-3.959144/4.139
=-95.65 %

where

Note: The Operating Income data used here is two times the semi-annual (Nov. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feedback  (LSE:FDBK) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Feedback's WACC % is 8.48%. Feedback's ROIC % is -90.59% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Feedback ROIC % Related Terms

Thank you for viewing the detailed overview of Feedback's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Feedback (LSE:FDBK) Business Description

Traded in Other Exchanges
N/A
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines